RxDoctor Payments Data

Simon Garceau

Orthopaedic Surgery · New York, NYNPI 1962064378

Payments from drug & device makers

What this record shows

This record is dominated by education: $19,833 of the $20,167 with a category attached, or 98.3%. Smith+Nephew accounts for 98.3% of it on its own, with 3 other manufacturers making up the rest.

$20,167in general payments, 2019–2025

Across 8 payments — averaging $2520.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Stryker$223
  • Zimmer Biomet$94
  • Cumberland Pharmaceuticals, Inc.$16
$625,587in research payments, 2019–2025

Across 11 payments — averaging $56,872 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Next Science LLC$626K

What the payments were for

  • Food & beverage$3332%
  • Education$19,83398%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$20,167 in reported general payments places this provider in the 75th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →